Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Arbutus Biopharma Stock News

ABUSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$3.28

At close: Apr 14 EDT

$3.29

0.010.30%

Pre-Market: 4:36 PM EDT

Arbutus Biopharma (ABUS) Forecast

News

Earnings Arbutus Biopharma (ABUS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Arbutus Biopharma Stock News | NASDAQ:ABUS | Benzinga

Get the latest news on Arbutus Biopharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Arbutus Biopharma performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, March 28, 2025

Arbutus Biopharma shares are trading higher o...
Benzinga Newsdesk - Mar 28, 2025, 3:21PM
Chardan Capital Maintains Buy on Arbutus Biop...
Benzinga Newsdesk - Mar 28, 2025, 8:39AM

Thursday, March 27, 2025

Arbutus Biopharma FY 2024 GAAP EPS $(0.38) Up...
Benzinga Newsdesk - Mar 27, 2025, 7:43AM

Monday, March 03, 2025

Roviant Sciences Subsidiary, Genevant Science...
Benzinga Newsdesk - Mar 3, 2025, 9:16AM

Tuesday, February 25, 2025

Arbutus Biopharma Appoints Lindsay Androski A...
Benzinga Newsdesk - Feb 25, 2025, 7:47AM

Tuesday, January 21, 2025

HC Wainwright & Co. Reiterates Buy on Arbutus...
Benzinga Newsdesk - Jan 21, 2025, 8:07AM

Monday, January 13, 2025

Arbutus Biopharma Held $123M In Cash Balance,...
Benzinga Newsdesk - Jan 13, 2025, 7:46AM

Tuesday, December 03, 2024

Whitefort Capital Sends Letter To Arbutus Bio...
Benzinga Newsdesk - Dec 3, 2024, 8:24AM

Wednesday, November 20, 2024

Walmart To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor - Nov 20, 2024, 7:45AM
Chardan Capital Maintains Buy on Arbutus Biop...
Benzinga Newsdesk - Nov 20, 2024, 5:58AM

Monday, November 18, 2024

HC Wainwright & Co. Reiterates Buy on Arbutus...
Benzinga Newsdesk - Nov 18, 2024, 7:17AM

Friday, November 15, 2024

Barinthus Biotherapeutics shares are trading ...
Benzinga Newsdesk - Nov 15, 2024, 1:19PM
Arbutus And Barinthus Bio Report IM-PROVE II ...
Benzinga Newsdesk - Nov 15, 2024, 11:02AM

Thursday, November 07, 2024

HC Wainwright & Co. Reiterates Buy on Arbutus...
Benzinga Newsdesk - Nov 7, 2024, 8:05AM
Chardan Capital Maintains Buy on Arbutus Biop...
Benzinga Newsdesk - Nov 6, 2024, 7:21PM

Wednesday, November 06, 2024

As Of September 30, 2024, Arbutus Had Cash, C...
Benzinga Newsdesk - Nov 6, 2024, 7:43AM
Arbutus Biopharma Q3 2024 GAAP EPS $(0.10) Mi...
Benzinga Newsdesk - Nov 6, 2024, 7:40AM

Tuesday, October 15, 2024

Arbutus Announces Multiple Abstracts Highligh...
Benzinga Newsdesk - Oct 15, 2024, 8:37AM

Thursday, October 03, 2024

Alnylam's Concedes Its Patent Infringement Case Against Moderna's COVID-19 Vaccine
Vandana Singh - Oct 3, 2024, 12:00PM

Thursday, September 05, 2024

Jefferies Maintains Buy on Arbutus Biopharma,...
Benzinga Newsdesk - Sep 5, 2024, 7:06PM

Friday, August 02, 2024

JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk - Aug 2, 2024, 1:55PM

Thursday, August 01, 2024

Trading Halt: Halt status updated at 7:55:00 ...
Benzinga Newsdesk - Aug 1, 2024, 7:55AM
Arbutus Will Cease Discovery Efforts And Disc...
Benzinga Newsdesk - Aug 1, 2024, 7:35AM
Arbutus Biopharma Q2 2024 GAAP EPS $(0.11) Mi...
Benzinga Newsdesk - Aug 1, 2024, 7:32AM
Trading Halt: Halted at 7:25:00 a.m. ET - Tra...
Benzinga Newsdesk - Aug 1, 2024, 7:25AM

Friday, June 07, 2024

HC Wainwright & Co. Reiterates Buy on Arbutus...
Benzinga Newsdesk - Jun 7, 2024, 11:29AM

Thursday, June 06, 2024

Barinthus Biotherapeutics Presents Updated Da...
Benzinga Newsdesk - Jun 6, 2024, 11:16AM
HC Wainwright & Co. Reiterates Buy on Arbutus...
Benzinga Newsdesk - Jun 6, 2024, 6:36AM

Wednesday, June 05, 2024

Chardan Capital Maintains Buy on Arbutus Biop...
Benzinga Newsdesk - Jun 5, 2024, 4:20PM
Arbutus's Imdusiran Combined With Short-Term ...
Benzinga Newsdesk - Jun 5, 2024, 3:50AM

Wednesday, May 22, 2024

Arbutus Biopharma Announces Presentation Of I...
Benzinga Newsdesk - May 22, 2024, 2:29AM

Monday, May 20, 2024

Genevant Sciences And Arbutus Biopharma Win D...
Benzinga Newsdesk - May 20, 2024, 12:52PM

Friday, May 03, 2024

Chardan Capital Reiterates Buy on Arbutus Bio...
Benzinga Newsdesk - May 3, 2024, 9:21AM

Thursday, May 02, 2024

Arbutus Biopharma Q1 EPS $(0.10) Beats $(0.11...
Benzinga Newsdesk - May 2, 2024, 7:31AM

Thursday, April 04, 2024

Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge
Vandana Singh - Apr 4, 2024, 2:32PM
Moderna Shares Slip Over Covid Vaccine Patent Dispute, But Chart Signals Potential Rebound Ahead
Surbhi Jain - Apr 4, 2024, 9:34AM
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk - Apr 4, 2024, 8:49AM
Arbutus Biopharma Announces Claim Constructio...
Benzinga Newsdesk - Apr 4, 2024, 8:42AM

Wednesday, April 03, 2024

Arbutus Stock Soars 20% As It Heads To Trial With Moderna In Covid Vaccine Patent Claim
Neil Dennis - Apr 3, 2024, 3:37PM
Arbutus Biopharma shares are trading higher a...
Benzinga Newsdesk - Apr 3, 2024, 12:57PM
Watching Arbutus Biopharma; Traders Circulate...
Benzinga Newsdesk - Apr 3, 2024, 12:22PM

Friday, March 01, 2024

Chardan Capital Reiterates Buy on Arbutus Bio...
Benzinga Newsdesk - Mar 1, 2024, 7:48AM
HC Wainwright & Co. Maintains Buy on Arbutus ...
Benzinga Newsdesk - Mar 1, 2024, 7:22AM

Thursday, February 29, 2024

Arbutus Biopharma's 2023 End Cash And Investm...
Benzinga Newsdesk - Feb 29, 2024, 7:40AM
Arbutus Biopharma Q4 EPS $(0.12), Inline, Sal...
Benzinga Newsdesk - Feb 29, 2024, 7:36AM
Earnings Scheduled For February 29, 2024
Benzinga Insights - Feb 29, 2024, 5:15AM

Thursday, February 08, 2024

Watching Arbutus Biopharma; Hearing Jefferies...
Benzinga Newsdesk - Feb 8, 2024, 1:13PM

Thursday, November 09, 2023

Barinthus Bio Said Initial Data From The Combination Of Imdusiran And VTP-300 Show Meaningful Reductions Of HBsAg Levels That Were Maintained Well Below Baseline.
Charles Gross - Nov 9, 2023, 4:27PM

Tuesday, November 07, 2023

Arbutus Biopharma Q3 2023 EPS $(0.12) Misses ...
Benzinga Newsdesk - Nov 7, 2023, 7:34AM
Arbutus Says Announces Workforce Reduction Of...
Benzinga Newsdesk - Nov 7, 2023, 7:32AM

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved